Skip to main content

Published

Molnupiravir for treating COVID-19 [NICE]
National Institute for Health and Care Excellence (NICE); 2026.
https://www.nice.org.uk/guidance/ta1056
[Technology appraisal guidance TA1056. Last updated: 26 February 2026. NICE removed sotrovimab from recommendation 1.1. This is because GlaxoSmithKline has discontinued manufacturing, supply, distribution and marketing of sotrovimab in the UK.]
Freely available online

Age Groups
Adults
Older People
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Community Clinics
Emergency Department
End of Life Care in the Community
General Practice
Home and Social Settings
Hospital Ward
Intensive Care
Residential and Nursing Homes
Urgent Care in the Community
Staff Groups
Medic
Nurse
Nurse Specialist
Pharmacist
Physician Associate